World · Singapore Bureau
Singapore research network named WHO collaborating centre for clinical trials
ADVANCE-ID has been formally appointed as a World Health Organization collaborating centre, strengthening the region's capacity to conduct clinical research on infectious diseases. The designation will enable the network to work with international partners to enhance disease prevention, detection and control efforts across South and Southeast Asia.
LSN Singapore ·
A Singapore-based research network has been appointed as a World Health Organization collaborating centre for clinical trials, marking a significant boost to the region's infectious disease research capabilities.
The appointment recognizes ADVANCE-ID's expertise and infrastructure in conducting rigorous clinical studies on infectious diseases affecting populations across South and Southeast Asia. As a WHO collaborating centre, the network will serve as a hub for advancing evidence-based clinical research and translating findings into public health practice.
The designation enables ADVANCE-ID to strengthen partnerships with other regional and international institutions, facilitating collaborative research efforts that address priority infectious disease challenges. Through these partnerships, the network will work to enhance surveillance systems, develop diagnostic tools, and accelerate the evaluation of new treatment and prevention strategies.
The appointment underscores Singapore's role as a regional research hub and reflects growing international confidence in the capabilities of local scientific institutions. It positions ADVANCE-ID to play a key role in coordinating multi-country clinical trials and building research capacity among participating nations, ultimately supporting more effective responses to infectious disease threats in the region.